Skip to content
Subscriber Only

Roche Chief Says Covid Test Growth to Abate in Second Half

  • Swiss drugmaker’s shares drop in Zurich trading on outlook
  • CEO Schwan ‘very confident’ on meeting forecast for this year
Video player cover image
WATCH: Roche is confident of meeting its forecasts, CEO Severin Schwan tells Bloomberg.(Source: Bloomberg)
Updated on

Roche Holding AG said growth momentum for its Covid-19 testing business will probably abate in coming months, signaling a leveling off of the jackpot that fueled sales lately.

Roche’s diagnostics unit swiftly developed a wide array of tests in response to the pandemic, buoying sales and making up for a more difficult time at the pharmaceuticals division, where aging cancer medicines face competition.